Bailard Inc. Takes Position in Enhabit, Inc. $EHAB

Bailard Inc. purchased a new position in Enhabit, Inc. (NYSE:EHAB) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 55,200 shares of the company’s stock, valued at approximately $442,000.

Other large investors also recently added to or reduced their stakes in the company. Osaic Holdings Inc. grew its position in Enhabit by 337.5% during the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after buying an additional 2,018 shares in the last quarter. State of Alaska Department of Revenue bought a new stake in shares of Enhabit during the 3rd quarter valued at about $27,000. Tower Research Capital LLC TRC boosted its position in shares of Enhabit by 82.9% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock valued at $44,000 after acquiring an additional 2,059 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Enhabit by 523.1% during the second quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock worth $56,000 after purchasing an additional 4,865 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of Enhabit by 110,987.5% in the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after purchasing an additional 8,879 shares during the last quarter.

Enhabit Price Performance

Shares of Enhabit stock opened at $10.82 on Friday. Enhabit, Inc. has a 52-week low of $6.47 and a 52-week high of $11.35. The stock has a market capitalization of $547.50 million, a price-to-earnings ratio of -43.27 and a beta of 1.66. The company has a fifty day moving average of $9.54 and a 200-day moving average of $8.37. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58.

Enhabit (NYSE:EHAB) last issued its earnings results on Wednesday, November 5th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.05. The company had revenue of $263.60 million for the quarter, compared to analysts’ expectations of $267.08 million. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Equities research analysts expect that Enhabit, Inc. will post 0.22 EPS for the current year.

Wall Street Analyst Weigh In

EHAB has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a research report on Monday, December 29th. Truist Financial set a $10.50 price objective on shares of Enhabit and gave the stock a “hold” rating in a report on Wednesday, January 7th. Citigroup reiterated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Finally, TD Cowen upgraded Enhabit to a “buy” rating in a research report on Tuesday, January 13th. Six investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Enhabit has a consensus rating of “Moderate Buy” and a consensus price target of $12.10.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.